+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 3Months - 12Months
All Genders
ID07596147

Study Comparing SAFE Early Intervention and Neurodevelopmental Treatment for High-Risk Infants Aged 3 to 12 Months

Led by Gazi University · Updated on 2026-05-19

34

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of the SAFE early intervention approach on upper extremity function, fine motor skills, and overall developmental outcomes in high-risk infants aged 3 to 12 months. This randomized controlled study compares the SAFE program with conventional Neurodevelopmental Treatment NDT to find which method better supports early motor and developmental progress. The study involves infants with neurodevelopmental risk factors such as perinatal stroke, prematurity, and brain injuries. The study includes two groups one receiving the SAFE early intervention program and the other receiving NDT. Both interventions last for 8 weeks, with sessions held 5 days per week. The SAFE program involves age-appropriate activities that promote voluntary movements, sensory stimulation, fine motor skills, postural control, and infant-parent interaction through daily routines and home-based activities. The NDT group receives conventional treatments targeting posture, muscle tone, motor development, balance, and fine motor skills. Families also receive education and support for home-based activities, with follow-ups through home visits and weekly phone calls. Participants are assessed before and after the 8-week intervention by a physiotherapist who does not know group assignments. Assessments include the Hand Assessment for Infants HAI, Peabody Developmental Motor Scales PDMS-2, Canadian Occupational Performance Measure COPM, and PedsQL Infant Quality of Life Scale. The study monitors adherence to the intervention programs and tracks developmental progress to evaluate which approach offers better improvements for high-risk infants. Total participation spans the 8-week intervention period with regular monitoring and support.

CONDITIONS

Brief Title

SAFE Early Intervention for At-Risk Infants

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here